Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies.

MLA

Stokowski, Renee, et al. “Clinical Performance of Non-Invasive Prenatal Testing (NIPT) Using Targeted Cell-Free DNA Analysis in Maternal Plasma with Microarrays or next Generation Sequencing (NGS) Is Consistent across Multiple Controlled Clinical Studies.” Prenatal Diagnosis, vol. 35, no. 12, Dec. 2015, pp. 1243–46. EBSCOhost, https://doi.org/10.1002/pd.4686.

APA

Stokowski, R., Wang, E., White, K., Batey, A., Jacobsson, B., Brar, H., Balanarasimha, M., Hollemon, D., Sparks, A., Nicolaides, K., & Musci, T. J. (2015). Clinical performance of non-invasive prenatal testing (NIPT) using targeted cell-free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies. Prenatal Diagnosis, 35(12), 1243–1246. https://doi.org/10.1002/pd.4686

Chicago

Stokowski, Renee, Eric Wang, Karen White, Annette Batey, Bo Jacobsson, Herb Brar, Madhumitha Balanarasimha, et al. 2015. “Clinical Performance of Non-Invasive Prenatal Testing (NIPT) Using Targeted Cell-Free DNA Analysis in Maternal Plasma with Microarrays or next Generation Sequencing (NGS) Is Consistent across Multiple Controlled Clinical Studies.” Prenatal Diagnosis 35 (12): 1243–46. doi:10.1002/pd.4686.